Epstein-Barr virus-associated B-cell non-Hodgkin lymphoma following treatment of hairy cell leukemia with cladribine

Blood. 2003 Nov 1;102(9):3457-8. doi: 10.1182/blood-2003-07-2494.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use
  • Cladribine / adverse effects*
  • Cladribine / therapeutic use
  • Epstein-Barr Virus Infections / complications*
  • Humans
  • Leukemia, Hairy Cell / drug therapy
  • Leukemia, Hairy Cell / pathology*
  • Lymphoma, B-Cell / etiology
  • Lymphoma, B-Cell / virology*
  • Lymphoma, Large B-Cell, Diffuse / etiology
  • Lymphoma, Large B-Cell, Diffuse / virology
  • Middle Aged
  • Neoplasms, Second Primary / etiology
  • Neoplasms, Second Primary / virology

Substances

  • Antineoplastic Agents
  • Cladribine